Vibrant TherapeuticsTarlatamabVIB193CatumaxomabLUSCPAADLUADTebentafuspCHOLKIRC+1 more
…n of prodrugs with tumor-specific protease-mediated activation, Vibrant Therapeutics has developed VIB193, the first masked TCE prodrug targeting bo…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Vibrant Therapeutics ×
Vibrant Therapeutics
This institution is selected. Its supporting articles are shown below.